NPI: 1912952110 · CARTHAGE, MS 39051 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/24/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/24/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,790 | $149K |
| 2019 | 11,845 | $173K |
| 2020 | 9,403 | $109K |
| 2021 | 9,966 | $122K |
| 2022 | 8,946 | $149K |
| 2023 | 3,030 | $155K |
| 2024 | 1,889 | $106K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 16,933 | 1,669 | $661K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 17,671 | 988 | $244K |
| 83970 | 919 | 648 | $21K | |
| A4657 | Syringe, with or without needle, each | 2,790 | 1,178 | $11K |
| J1756 | Injection, iron sucrose, 1 mg | 2,838 | 655 | $9K |
| 82728 | 460 | 364 | $4K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,479 | 882 | $3K |
| 83550 | 389 | 302 | $2K | |
| 85041 | 1,041 | 826 | $2K | |
| 83540 | 474 | 363 | $2K | |
| 85045 | 535 | 454 | $2K | |
| 85048 | 1,017 | 803 | $2K | |
| 82108 | 53 | 43 | $1K | |
| 82607 | 31 | 29 | $385.30 | |
| 82746 | 31 | 29 | $375.86 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 191 | 86 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 992 | 599 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 25 | 12 | $0.00 |